Functional inactivation of white blood cells by Mirasol treatment

Transfusion

Volumn 46, Issue 4, 2006, Pages 642-648

  Fast, Loren D ^a   Dileone, Gilbert ^b   Li, Junzhi ^b   Goodrich, Raymond ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NUCLEIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; RIBOFLAVIN; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; IMMUNOREGULATION; IMMUNOSTIMULATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LIGHT; LIGHT EXPOSURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MIRASOL PRT TREATMENT; PRIMED LYMPHOCYTE TYPING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION;

ANTI-INFECTIVE AGENTS; BLOOD DONORS; CELL DIVISION; COLONY-FORMING UNITS ASSAY; CYTOKINES; HUMANS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; RIBOFLAVIN; T-LYMPHOCYTES;

EID: 33645289412     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00777.x     Document Type: Article

References (16)

1. Vamvakas EC Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001 97 1180 95.
2. Lee JH Klein H. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes. Bailliere's Clin Hematol 2000 13 585 600.
3. Gould DS Auchincloss H Jr.. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999 20 77 82.
4. Kumar V Motheral T Luzniak G Goodrich R. Mirasol pathogen reduction technology: riboflavin-based plasma process inactivates intracellular and extracellular human immunodeficiency. J Clin Apheresis 2003 18 84.
5. Ruane P Edrich R Gampp D et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 877 85.
6. Goodrich L Douglas I Urisote M. Riboflavin photoinactivation procedure inactivates significant levels of bacteria and produces a culture negative product. Transfusion 2002 42 16S.
7. Goodrich L Ghielli M Hansen E et al. Riboflavin and UV light inactivate enveloped and non-enveloped viruses in platelet concentrates which maintain cell quality. Vox Sang 2002 83 111.
8. Goodrich R. Inactivation of viruses in blood products (platelets, plasma, and red cells). Transfus Clin Biol 2001 8 103S.
9. Fast L DiLeone G Edson C Purmal A. PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation. Transfusion 2002 42 1318 25.
10. Fast L. The effect of exposing murine splenocytes to UVB light, psoralen plus UVA light or gamma irradiation on in vitro and in vivo immune responses. Transfusion 2003 43 576 83.
11. Iwasaki A Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004 10 987 95.
12. Greenwald R Freeman G Sharpe A. The B7 family revisited. Annu Rev Immunol 2005 23 515 48.
13. Andre-Schmutz I Le Deist F Hacein-Bey-Abina S et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002 360 130 7.
14. Luban N. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001 38 34 45.
15. Grass JA Wafa T Reames A et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. J Immunol 1999 93 3140 7.
16. Ohto H Yasuda H Noguchi M Abe R. Risk of transfusion-associated graft-versus-host disease as a result of direct donations from relatives. Transfusion 1992 2 691.